admin, Author at Pixium Vision

Gérard Hascoët

Gérard Hascoët began his career in the medical technology business of Thomson CGR. As a serial entrepreneur, in 1985, he founded Technomed International, which is now a part of EDAP TMS, a Company dedicated to non-invasive medical treatment in urology. In 1993, he founded Sometec, a hemodynamic monitoring company acquired by Arrow International, and IMMI, a neurosurgical robotics company acquired by ISS. From 2008 to 2011, Gérard was CEO of SpineVision, a spinal implant company, and he continues to serve on the company’s Board of Directors. In 2009, he co-founded MD Start, a European incubator for medical technology companies, where he holds the position of Executive Chairman. Gérard is a Venture Partner of Sofinnova, one of the leading European healthcare venture capital firms. He is also Chairman of EOS Imaging, Chairman of CorWave, Director of the Board of LimFlow and Ablacare. Gérard holds a degree in engineering from E.C.E Paris.

admin2019-10-11T11:43:22+02:00September 9th, 2019|Board of Directors|

Marie Meynadier

Director

Marie Meynadier has over 25 years of experience int the high tech and medical device Industries. After receiving her doctorate, she joined Bellcore (Red Bank, NJ) and ATT Bell Labs (Murray Hill, NJ), where she conducted research on semiconductor devices. She then returned to France to lead the management of major national and international development programs in electronics, optics and microelectronics, which enabled the creation of several start-ups in these areas. Marie joined the medical field in 1999, taking leadership at the start-up Biospace lab, where she specialized in preclinical imaging and rapidly turned it into a profitable business. She has been exclusively dedicated to EOS imaging since 2008. Marie holds a degree in Electronic Engineering from Sup Telecom and a PhD (Doctorate) from the Ecole Normale Supérieure.

admin2019-09-09T14:22:00+02:00September 9th, 2019|Board of Directors|

Bernard Gilly

Chairman

Bernard Gilly has over 20 years of experience in the financial and pharmaceutical sectors, and as an entrepreneur. He was Vice-President R&D for 5 years at Pasteur Mérieux Connaught (now Sanofi Pasteur). Afterwards, he became the CEO of Transgene from 1992 to 2000, heading the Company’s listing and raising over $120 million. He later joined Sofinnova Partners in Paris (2000-2005). In 2005, he founded and became the CEO of Fovea Pharmaceuticals. After Fovea was acquired by Sanofi in 2009, he became Executive Vice President of the Ophthalmology Division of Sanofi. Lastly, he founded Pixium Vision in 2011.

admin2019-09-09T14:19:51+02:00September 9th, 2019|Board of Directors|

Ralf Hornig, PhD
Director of Clinical Affairs

Dr. Ralf Hornig has more than 20 years of experience in Retinal Implant research and Artificial Vision. He received a degree in electrical engineering from the University of Hanover, Germany in 1995 and the PhD degree with highest honor in 2001 at the Technical University of Berlin, Germany. Between 1996 and 2001 his research activities included system tests, computer simulations, ASIC development as well as pre-clinical test for retina implants at the University of Bonn, Germany. From 2001 to 2012 he was member of the management team at Intelligent Medical Implants (IMI), where he was responsible for pre-clinical and clinical trials. He remains a scientific peer reviewer for international publications.

admin2022-12-21T11:49:41+01:00September 9th, 2019|Management|

Karine Chevrie, PhD
Regulatory Affairs and Quality Director

Karine Chevrie has a PhD in Biochemistry and 20 years’ experience in the field of medical devices. During her career, she was notably in charge of regulatory strategies which contributed to obtaining CE marks and FDA approvals. She also built and managed quality management systems complying to ISO 13485 and 21CFR820 US regulation. From 2006 to 2015, Karine Chevrie held the position of Regulatory Affairs and Quality Director at EOS Imaging. Previously, she was for 7 years in charge of medical devices that hold a biological risk at AFSSAPS (now ANSM). In that framework, she participated in several work groups at the European Commission.

admin2022-12-21T11:33:38+01:00September 9th, 2019|Management|

Lloyd Diamond
CEO

Lloyd Diamond, a US citizen, is a seasoned medtech executive and CEO with 25 years of disruptive technology commercialization experience in the life science industry. He most recently served as the CEO of Precise Light Surgical, a commercially ready medical device company in Silicon Valley. Prior to that, he was the CEO of Bonesupport AB, a European orthobiologic company, where he drove rapid market penetration in Europe and the US which led to a successful IPO on the NASDAQ OMX in Stockholm. Lloyd has first-hand experience in the ophthalmology segment as he was responsible for managing Lumenis’ global surgical and vision franchises. He has commercialized many other disruptive technology platforms including at Kyphon and Laserscope. Lloyd received a dual degree in Biochemistry and Marketing from Florida Atlantic University and an MBA from the Thunderbird School of Global Management at Arizona State University.

admin2022-12-21T11:29:30+01:00September 9th, 2019|Board of Directors, Management|

2019 KOL EVENT MEETING ON PROMISING RESULTS WITH PRIMA IN ADVANCED DRY-AGE-RELATED MACULAR DEGENERATION (AMD) – SHORT VERSION

Highlights of the KOL meeting : Three ophthalmology experts discuss PRIMA in advanced dry-AMD :

· Pr. F. Holz : “Real world unmet medical need : atrophic dry-AMD”

· Pr. D. Palanker : “PRIMA inventor’s motivation”

· Pr. J-A. Sahel : “First in human study PRIMA in AMD”

To have access to the Powerpoint presentation, please click on the title

admin2019-09-09T00:17:50+02:00September 3rd, 2019|Events|

About admin